Goldberg Law PC (the "Firm") announces that a class action lawsuit has been filed against Warren Resources, Inc. ("Warren" or the "Company") WRES WRESQ. Investors who purchased or otherwise acquired shares between November 4, 2014 and June 2, 2016 inclusive (the "Class Period") are encouraged to contact the Firm in advance of the October 11, 2016 lead plaintiff motion deadline.
If you are a shareholder who suffered a loss during the Class Period, click here to participate. In addition, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm's website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the complaint, Warren issued false and misleading statements that it was prepared to handle market fluctuations, when the Company was actually becoming increasingly insolvent. Thus, Warren's statements about business, operations, and prospects were false and misleading and/or lacked a reasonable basis. On June 2, 2016, the Company filed for Chapter 11 bankruptcy. When this news was announced to the public, shares of Warren decreased in value, causing investors harm.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160831006354/en/
Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian
Schall, Esq., 800-977-7401
info@goldberglawpc.com
www.Goldberglawpc.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.